The European Medicines Agency (EMA) has given its backing to the Johnson & Johnson Covid-19 vaccine, saying the overall benefit-risk remains positive, despite warning about the very rare possible side effect of blood clots.

The EU drug regulator’s safety committee conducted an investigation into the side effects of the Johnson & Johnson vaccine after the US Food and Drug Administration (FDA) suspended its use in America earlier this month “out of an abundance of caution.”

The FDA’s move led to Johnson & Johnson delaying its rollout of the vaccine throughout Europe to allow for a full assessment of the risks, with the EMA looking into all eight complaints of clots – including one fatal – among the 7 million US recipients of the shot. (RT)